These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15928667)

  • 1. Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon.
    Donnelly ET; Bardwell H; Thomas GA; Williams ED; Hoper M; Crowe P; McCluggage WG; Stevenson M; Phillips DH; Hewer A; Osborne MR; Campbell FC
    Br J Cancer; 2005 Jun; 92(12):2160-5. PubMed ID: 15928667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of N-methyl-N-nitrosourea-induced crypt restricted metallothionein immunopositivity in mouse colon by a non-genotoxic diet-related chemical.
    Donnelly ET; Bardwell H; Thomas GA; Williams ED; Hoper M; Crowe P; McCluggage WG; Stevenson M; Phillips DH; Hewer A; Osborne MR; Campbell FC
    Carcinogenesis; 2004 May; 25(5):847-55. PubMed ID: 14729593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crypt-restricted metallothionein immunopositivity in murine colon: validation of a model for studies of somatic stem cell mutation.
    Anne Cook H; Williams D; Anne Thomas G
    J Pathol; 2000 Jul; 191(3):306-12. PubMed ID: 10878553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histomorphological and immunohistochemical characterization of colonic aberrant crypt foci in rats: relationship to growth factor expression.
    Thorup I
    Carcinogenesis; 1997 Mar; 18(3):465-72. PubMed ID: 9067543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA adduct formation and assessment of aberrant crypt foci in vivo in the rat colon mucosa after treatment with N-methyl-N-nitrosourea.
    Qin X; Zarkovic M; Nakatsuru Y; Arai M; Oda H; Ishikawa T
    Carcinogenesis; 1994 May; 15(5):851-5. PubMed ID: 8200086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of diets containing high and low risk factors for colon cancer on early stages of carcinogenesis in human flora-associated (HFA) rats.
    Hambly RJ; Rumney CJ; Cunninghame M; Fletcher JM; Rijken PJ; Rowland IR
    Carcinogenesis; 1997 Aug; 18(8):1535-9. PubMed ID: 9276627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid.
    Magnuson BA; Bird RP
    Cancer Lett; 1993 Jan; 68(1):15-23. PubMed ID: 8422645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of aberrant crypt foci induced by the two heterocyclic amines 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) and 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP) in the development of colon cancer in mice.
    Kristiansen E
    Cancer Lett; 1996 Dec; 110(1-2):187-92. PubMed ID: 9018100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of aberrant crypt foci by dietary fat and caloric restriction: the effects of delayed intervention.
    Lasko CM; Bird RP
    Cancer Epidemiol Biomarkers Prev; 1995; 4(1):49-55. PubMed ID: 7894324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic aberrant crypts may originate from impaired fissioning: relevance to increased risk of neoplasia.
    Kristt D; Bryan K; Gal R
    Hum Pathol; 1999 Dec; 30(12):1449-58. PubMed ID: 10667423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutations of APC and K-ras gene in aberrant crypt foci from human colon].
    Yuan P; Sun M; Zhang J; Zhu X; Shi D
    Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):35-8. PubMed ID: 11866955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scanning electron microscopy of aberrant crypt foci in human colorectal mucosa.
    Vaccina F; Scorcioni F; Pedroni M; Tamassia MG; De Leon MP; De Pol A; Marzona L; Roncucci L
    Anticancer Res; 1998; 18(5A):3451-6. PubMed ID: 9858923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor promotion by fecapentaene-12 in a rat colon carcinogenesis model.
    Zarkovic M; Qin X; Nakatsuru Y; Oda H; Nakamura T; Shamsuddin AM; Ishikawa T
    Carcinogenesis; 1993 Jul; 14(7):1261-4. PubMed ID: 8330337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous development of aberrant crypt foci in F344 rats.
    Furukawa F; Nishikawa A; Kitahori Y; Tanakamaru Z; Hirose M
    J Exp Clin Cancer Res; 2002 Jun; 21(2):197-201. PubMed ID: 12148578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression patterns distinguish colonoscopically isolated human aberrant crypt foci from normal colonic mucosa.
    Glebov OK; Rodriguez LM; Soballe P; DeNobile J; Cliatt J; Nakahara K; Kirsch IR
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2253-62. PubMed ID: 17119054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.
    Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J
    Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallothionein colon crypt immuno-positivity as a rapid in vivo essay for drug efficacy studies.
    Mori F; Della Rocca C; Lazzaro D
    In Vivo; 2012; 26(4):693-702. PubMed ID: 22773584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aberrant crypt foci by chemopreventive agents.
    Olivo S; Wargovich MJ
    In Vivo; 1998; 12(2):159-66. PubMed ID: 9627797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
    Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.